POLYMEDNSE25 May 2021

Poly Medicure Limited

4,025words
1turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
: - 531768 The Manager, BSE Limited, Department of Corporate Services, Phirozee Jeejeebhoy Towers, Dalal Sh·eet, Mumbai- 400001 . p M E D IYMED !CAL DEV ICES We Care As We Cure Scrip Code
100%
Operation 2001 Expansion of Faridabad Plant 2002 JV in Egypt 2004 Faridabad Plant-2 Extension (100% EOU) 2006 Acquired 75% of US Safety Syringes 2007 New Plant Haridwar 2009 China Plant 2011
75%
of Faridabad Plant 2002 JV in Egypt 2004 Faridabad Plant-2 Extension (100% EOU) 2006 Acquired 75% of US Safety Syringes 2007 New Plant Haridwar 2009 China Plant 2011 Company Listed in NSE
11%
de 7 INDIAN MEDICAL DEVICES MARKET 4th Largest Market in in Asia $11 Bn Current Market Size 9-11% CAGR Growth $50 Bn Market Size by 2025  After Japan, China & South Korea  Including implant
70%
associates in India, 10+ in more in pipeline Europe  Broad portfolio of hospital products  70% + POLYMED branded sales and rest for most patients Private label Polymed Sales By Geography P
31%
for most patients Private label Polymed Sales By Geography Polymed Sales By Product Category 31% 8% 4% 3% 5% 9%  Increased new products in premium and value tier for public and private Hos
8%
most patients Private label Polymed Sales By Geography Polymed Sales By Product Category 31% 8% 4% 3% 5% 9%  Increased new products in premium and value tier for public and private Hospita
4%
t patients Private label Polymed Sales By Geography Polymed Sales By Product Category 31% 8% 4% 3% 5% 9%  Increased new products in premium and value tier for public and private Hospitals P
3%
tients Private label Polymed Sales By Geography Polymed Sales By Product Category 31% 8% 4% 3% 5% 9%  Increased new products in premium and value tier for public and private Hospitals Polym
5%
ts Private label Polymed Sales By Geography Polymed Sales By Product Category 31% 8% 4% 3% 5% 9%  Increased new products in premium and value tier for public and private Hospitals Polymed B
9%
Private label Polymed Sales By Geography Polymed Sales By Product Category 31% 8% 4% 3% 5% 9%  Increased new products in premium and value tier for public and private Hospitals Polymed Brand
30%
premium and value tier for public and private Hospitals Polymed Brand and OEM Private Label Sales 30% 69% 71% 70% Export India Infusion Therapy Surgery & Wound Drainage Blood Transfusion Anaes
Speaking time
Registered Office
1
Advertisement
Opening remarks
Registered Office
232 B, 3rd Floor, Okhla Industrial Estate, Phase III, New Delhi-110020, India Tel:- 91-11-33550700, 47317000, 26321838/99 For any general queries, Reach us at: info@polymedicure.com Visit: www.polymedicure.com
Advertisement
← All transcriptsPOLYMED stock page →